ID   EPHB2_HUMAN             Reviewed;         986 AA.
AC   P29323-2;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 5.
DT   12-OCT-2022, entry version 248.
DE   RecName: Full=Isoform 2 of Ephrin type-B receptor 2;
DE            EC=2.7.10.1;
DE   AltName: Full=Developmentally-regulated Eph-related tyrosine kinase;
DE   AltName: Full=ELK-related tyrosine kinase;
DE   AltName: Full=EPH tyrosine kinase 3;
DE   AltName: Full=EPH-like kinase 5;
DE            Short=EK5;
DE            Short=hEK5;
DE   AltName: Full=Renal carcinoma antigen NY-REN-47;
DE   AltName: Full=Tyrosine-protein kinase TYRO5;
DE   AltName: Full=Tyrosine-protein kinase receptor EPH-3;
DE   Contains:
DE     RecName: Full=EphB2/CTF1 {ECO:0000250|UniProtKB:P54763};
DE   Contains:
DE     RecName: Full=EphB2/CTF2 {ECO:0000250|UniProtKB:P54763};
DE   Flags: Precursor;
GN   Name=EPHB2; Synonyms=DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8033077;
RA   Kiyokawa E., Takai S., Tanaka M., Iwase T., Suzuki M., Xiang Y.Y.,
RA   Naito Y., Yamada K., Sugimura H., Kino I.;
RT   "Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in
RT   various human tumors.";
RL   Cancer Res. 54:3645-3650(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Fetal brain;
RX   PubMed=8589679; DOI=10.1093/hmg/4.11.2033;
RA   Ikegaki N., Tang X.X., Liu X.-G., Biegel J.A., Allen C., Yoshioka A.,
RA   Sulman E.P., Brodeur G.M., Pleasure D.E.;
RT   "Molecular characterization and chromosomal localization of DRT (EPHT3): a
RT   developmentally regulated human protein-tyrosine kinase gene of the EPH
RT   family.";
RL   Hum. Mol. Genet. 4:2033-2045(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=9696046; DOI=10.1038/sj.onc.1201960;
RA   Tang X.X., Pleasure D.E., Brodeur G.M., Ikegaki N.;
RT   "A variant transcript encoding an isoform of the human protein tyrosine
RT   kinase EPHB2 is generated by alternative splicing and alternative use of
RT   polyadenylation signals.";
RL   Oncogene 17:521-526(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-986 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7898931;
RA   Fox G.M., Holst P.L., Chute H.T., Lindberg R.A., Janssen A.M., Basu R.,
RA   Welcher A.A.;
RT   "cDNA cloning and tissue distribution of five human EPH-like receptor
RT   protein-tyrosine kinases.";
RL   Oncogene 10:897-905(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 509-986 (ISOFORM 2).
RC   TISSUE=Fetal brain;
RX   PubMed=7601466; DOI=10.1016/0888-7543(95)80224-a;
RA   Saito T., Seki N., Matsuda Y., Kitahara M., Murata M., Kanda N., Nomura N.,
RA   Yamamoto T., Hori T.-A.;
RT   "Identification of the human ERK gene as a putative receptor tyrosine
RT   kinase and its chromosomal localization to 1p36.1: a comparative mapping of
RT   human, mouse, and rat chromosomes.";
RL   Genomics 26:382-384(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 640-986 (ISOFORM 2).
RC   TISSUE=Gastric carcinoma;
RX   PubMed=7688222; DOI=10.1006/bbrc.1993.1878;
RA   Iwase T., Tanaka M., Suzuki M., Naito Y., Sugimura H., Kino I.;
RT   "Identification of protein-tyrosine kinase genes preferentially expressed
RT   in embryo stomach and gastric cancer.";
RL   Biochem. Biophys. Res. Commun. 194:698-705(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 652-712.
RX   PubMed=1648701;
RA   Chan J., Watt V.M.;
RT   "eek and erk, new members of the eph subclass of receptor protein-tyrosine
RT   kinases.";
RL   Oncogene 6:1057-1061(1991).
RN   [9]
RP   NOMENCLATURE.
RX   PubMed=9267020; DOI=10.1016/s0092-8674(00)80500-0;
RG   Eph nomenclature committee;
RT   "Unified nomenclature for Eph family receptors and their ligands, the
RT   ephrins.";
RL   Cell 90:403-404(1997).
RN   [10]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-983 (ISOFORM 2),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-984 (ISOFORM 3), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   POLYUBIQUITINATION, AND INTERACTION WITH SPSB1 AND SPSB4.
RX   PubMed=28931592; DOI=10.1091/mbc.e17-07-0450;
RA   Okumura F., Joo-Okumura A., Obara K., Petersen A., Nishikimi A., Fukui Y.,
RA   Nakatsukasa K., Kamura T.;
RT   "Ubiquitin ligase SPSB4 diminishes cell repulsive responses mediated by
RT   EphB2.";
RL   Mol. Biol. Cell 28:3532-3541(2017).
RN   [14]
RP   UBIQUITINATION BY RNF186, AND MUTAGENESIS OF LYS-787 AND LYS-891.
RX   PubMed=33280498; DOI=10.1080/15548627.2020.1851496;
RA   Zhang H., Cui Z., Cheng D., Du Y., Guo X., Gao R., Chen J., Sun W., He R.,
RA   Ma X., Peng Q., Martin B.N., Yan W., Rong Y., Wang C.;
RT   "RNF186 regulates EFNB1 (ephrin B1)-EPHB2-induced autophagy in the colonic
RT   epithelial cells for the maintenance of intestinal homeostasis.";
RL   Autophagy 17:3030-3047(2021).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 910-986 (ISOFORM SHORT).
RX   PubMed=9933164; DOI=10.1126/science.283.5403.833;
RA   Thanos C.D., Goodwill K.E., Bowie J.U.;
RT   "Oligomeric structure of the human EphB2 receptor SAM domain.";
RL   Science 283:833-836(1999).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 20-195 OF HOMODIMER IN COMPLEX
RP   WITH ANTAGONISTIC PEPTIDE, DISULFIDE BOND, AND SUBUNIT.
RX   PubMed=17897949; DOI=10.1074/jbc.m706340200;
RA   Chrencik J.E., Brooun A., Recht M.I., Nicola G., Davis L.K., Abagyan R.,
RA   Widmer H., Pasquale E.B., Kuhn P.;
RT   "Three-dimensional structure of the EphB2 receptor in complex with an
RT   antagonistic peptide reveals a novel mode of inhibition.";
RL   J. Biol. Chem. 282:36505-36513(2007).
RN   [17]
RP   VARIANTS PROSTATE CANCER HIS-199; SER-279; ASN-679 AND MET-909, AND
RP   FUNCTION AS A TUMOR SUPPRESSOR.
RX   PubMed=15300251; DOI=10.1038/ng1408;
RA   Huusko P., Ponciano-Jackson D., Wolf M., Kiefer J.A., Azorsa D.O.,
RA   Tuzmen S., Weaver D., Robbins C., Moses T., Allinen M., Hautaniemi S.,
RA   Chen Y., Elkahloun A., Basik M., Bova G.S., Bubendorf L., Lugli A.,
RA   Sauter G., Schleutker J., Ozcelik H., Elowe S., Pawson T., Trent J.M.,
RA   Carpten J.D., Kallioniemi O.-P., Mousses S.;
RT   "Nonsense-mediated decay microarray analysis identifies mutations of EPHB2
RT   in human prostate cancer.";
RL   Nat. Genet. 36:979-983(2004).
RN   [18]
RP   VARIANTS PROSTATE CANCER SER-279; ALA-650 AND VAL-883.
RX   PubMed=16155194; DOI=10.1136/jmg.2005.035790;
RA   Kittles R.A., Baffoe-Bonnie A.B., Moses T.Y., Robbins C.M., Ahaghotu C.,
RA   Huusko P., Pettaway C., Vijayakumar S., Bennett J., Hoke G., Mason T.,
RA   Weinrich S., Trent J.M., Collins F.S., Mousses S., Bailey-Wilson J.,
RA   Furbert-Harris P., Dunston G., Powell I.J., Carpten J.D.;
RT   "A common nonsense mutation in EphB2 is associated with prostate cancer
RT   risk in African American men with a positive family history.";
RL   J. Med. Genet. 43:507-511(2006).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-279; GLY-289; VAL-361; ASN-678 AND
RP   TRP-844.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [20]
RP   VARIANT BDPLT22 CYS-745, INVOLVEMENT IN BDPLT22, AND FUNCTION.
RX   PubMed=30213874; DOI=10.1182/blood-2018-04-845644;
RA   Berrou E., Soukaseum C., Favier R., Adam F., Elaib Z., Kauskot A.,
RA   Bordet J.C., Ballerini P., Loyau S., Feng M., Dias K., Muheidli A.,
RA   Girault S., Nurden A.T., Turro E., Ouwehand W.H., Denis C.V.,
RA   Jandrot-Perrus M., Rosa J.P., Nurden P., Bryckaert M.;
RT   "A mutation of the human EPHB2 gene leads to a major platelet functional
RT   defect.";
RL   Blood 132:2067-2077(2018).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=EPHB2v, Long;
CC         IsoId=P29323-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P29323-2; Sequence=VSP_003016, VSP_003017;
CC       Name=3;
CC         IsoId=P29323-3; Sequence=VSP_015713, VSP_003016, VSP_003017;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS229.2; -.
DR   RefSeq; NP_059145.2; NM_017449.4.
DR   ProteomicsDB; 54541; -.
DR   Ensembl; ENST00000374630.8; ENSP00000363761.3; ENSG00000133216.17.
DR   MANE-Select; ENST00000374630.8; ENSP00000363761.3; NM_017449.5; NP_059145.2.
DR   Proteomes; UP000005640; Chromosome 1.
PE   1: Evidence at protein level;
FT   MOTIF           984..986
FT                   /note="PDZ-binding (in isoform 2)"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         983
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
SQ   SEQUENCE   986 AA;  109874 MW;  4B9B532A48B754A6 CRC64;
     MALRRLGAAL LLLPLLAAVE ETLMDSTTAT AELGWMVHPP SGWEEVSGYD ENMNTIRTYQ
     VCNVFESSQN NWLRTKFIRR RGAHRIHVEM KFSVRDCSSI PSVPGSCKET FNLYYYEADF
     DSATKTFPNW MENPWVKVDT IAADESFSQV DLGGRVMKIN TEVRSFGPVS RSGFYLAFQD
     YGGCMSLIAV RVFYRKCPRI IQNGAIFQET LSGAESTSLV AARGSCIANA EEVDVPIKLY
     CNGDGEWLVP IGRCMCKAGF EAVENGTVCR GCPSGTFKAN QGDEACTHCP INSRTTSEGA
     TNCVCRNGYY RADLDPLDMP CTTIPSAPQA VISSVNETSL MLEWTPPRDS GGREDLVYNI
     ICKSCGSGRG ACTRCGDNVQ YAPRQLGLTE PRIYISDLLA HTQYTFEIQA VNGVTDQSPF
     SPQFASVNIT TNQAAPSAVS IMHQVSRTVD SITLSWSQPD QPNGVILDYE LQYYEKELSE
     YNATAIKSPT NTVTVQGLKA GAIYVFQVRA RTVAGYGRYS GKMYFQTMTE AEYQTSIQEK
     LPLIIGSSAA GLVFLIAVVV IAIVCNRRGF ERADSEYTDK LQHYTSGHMT PGMKIYIDPF
     TYEDPNEAVR EFAKEIDISC VKIEQVIGAG EFGEVCSGHL KLPGKREIFV AIKTLKSGYT
     EKQRRDFLSE ASIMGQFDHP NVIHLEGVVT KSTPVMIITE FMENGSLDSF LRQNDGQFTV
     IQLVGMLRGI AAGMKYLADM NYVHRDLAAR NILVNSNLVC KVSDFGLSRF LEDDTSDPTY
     TSALGGKIPI RWTAPEAIQY RKFTSASDVW SYGIVMWEVM SYGERPYWDM TNQDVINAIE
     QDYRLPPPMD CPSALHQLML DCWQKDRNHR PKFGQIVNTL DKMIRNPNSL KAMAPLSSGI
     NLPLLDRTIP DYTSFNTVDE WLEAIKMGQY KESFANAGFT SFDVVSQMMM EDILRVGVTL
     AGHQKKILNS IQVMRAQMNQ IQSVEV
//
